Type: News Releases
NEW YORK, November 2, 2016 – Reed Smith LLP represented Citron Pharma LLC, a privately held pharmaceutical company focused on developing and marketing generic products from diverse therapy segments, and its affiliate Lucid Pharma LLC, in the acquisition of their generic drug-related assets by ACETO Corporation (NASDAQ:ACET). ACETO is an international company engaged in the development, marketing, sale and distribution of human health products, pharmaceutical ingredients and performance chemicals. The deal was valued at approximately $412 million.
The Reed Smith team, co-led by New York partner Niket Rele and Pittsburgh partner Courtney C. Murray, included Pittsburgh associate John Algie. Additional support was provided by New York partner James R. Tandler, Chicago partner Benjamin L. Brimeyer, and New York associate Brent C. Vegliacich.
Read ACETO Corporation’s press release at aceto.com.